BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 2148146)

  • 21. A comparative study of the metabolic effects of injectable and oral contraceptives.
    Liew DF; Ng CS; Heng SH; Ratnam SS
    Contraception; 1986 Apr; 33(4):385-94. PubMed ID: 2942334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA; Bonnar J
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypophyseal reaction state during oral contraceptiva (author's transl)].
    Gitsch E; Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):599-601. PubMed ID: 6798764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral contraception and carbohydrate metabolism: III--practical implications].
    Hilal M
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA; Kazi AB; Kazi A; Ali N
    J Pak Med Assoc (1951); 1972 Aug; 22(8):218-25. PubMed ID: 12305803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus.
    Harvengt C
    Diabete Metab; 1992; 18(2):71-7. PubMed ID: 1511755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in glucose tolerance, serum insulin and blood lipids during contraceptive medication (oestrogen-gestagen) in metabolically-healthy women (author's transl)].
    Lageder H; Irsigler K; Schneider WH; Spona J; Bauer P; Wohlzogen FX
    Wien Klin Wochenschr; 1977 Apr; 89(8):276-81. PubMed ID: 855347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraception, mechanical contraception, and carbohydrate and lipid metabolism: a two-year study.
    Pribicevic V; Skrabalo Z; Lipovac V; Trenc S; Zadjelovic J; Rajkovic Z
    Int J Fertil; 1979; 24(2):114-9. PubMed ID: 40904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
    Prasad RN; Koh S; Ratnam SS
    Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between vascular headaches and low-dose oral contraceptives.
    Karsay K
    Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors.
    Watanabe RM; Azen CG; Roy S; Perlman JA; Bergman RN
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1277-83. PubMed ID: 7962320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral contraceptives and panic disorder.
    Deci PA; Lydiard RB; Santos AB; Arana GW
    J Clin Psychiatry; 1992 May; 53(5):163-5. PubMed ID: 1592843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations for the use of progestin-only contraceptives.
    Freeman S; Shulman LP
    J Am Acad Nurse Pract; 2010 Feb; 22(2):81-91. PubMed ID: 20132366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case for concern?
    Gartland A
    Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Thomas DB; Noonan L; Whitehead A
    Bull World Health Organ; 1985; 63(3):513-9. PubMed ID: 2931206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune reactivity of women on hormonal contraceptives. Phytohemagglutinin and concanavalin-A induced lymphocyte response.
    Gerretsen G; Kremer J; Bleumink E; Nater JP; de Gast GC; The TH
    Contraception; 1980 Jul; 22(1):25-9. PubMed ID: 7418405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic study of blood in women who had used oral contraceptives.
    Fridrichová I
    Neoplasma; 1990; 37(5):545-53. PubMed ID: 1700312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of an injectable progestogen contraceptive on blood coagulation and fibrinolysis.
    Whigham KA; Howie PW; Mack A; Prentice CR
    Br J Obstet Gynaecol; 1979 Oct; 86(10):806-9. PubMed ID: 508662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.